The business intelligence firm, the world's largest corporate holder of Bitcoin, is now sitting on nearly $1 billion in paper losses after the cryptocurrency's recent slump below its average acquisition cost, raising questions about its high-stakes treasury strategy.
The UK's economic recovery faces a significant drag from recently implemented fiscal tightening, with growth forecasts remaining subdued for the coming year, according to a leading economic forecaster.
TransDigm Group's recent acquisitions of Stellant Systems and Jet Parts Engineering, totaling over $3 billion, have analysts debating whether the moves solidify its lucrative aftermarket strategy or stretch its leveraged balance sheet too thin ahead of a critical earnings season.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
Energy Transfer LP announced a significant increase to its quarterly distribution alongside a multi-billion dollar capital expenditure plan for new pipeline and infrastructure projects, signaling confidence in its cash flow stability and long-term growth prospects.
The FDA has cleared Intuitive Surgical's latest robotic system for use in certain heart surgeries, marking a strategic expansion into one of healthcare's largest and most complex service lines and potentially reshaping hospital capital planning for robotics.
Shares of electrical connection specialist nVent Electric have surged nearly 80% in the past year, prompting investors to question whether the rally has outpaced the company's fundamental value. A deep dive into valuation metrics suggests caution may be warranted.
Micron Technology's stock has skyrocketed over 360% in the past year, fueled by insatiable AI-driven demand for memory chips. But with shares now trading at a significant premium to some traditional valuation models, investors face a critical question: has the rally run too far, too fast?
While the FTSE 100 grapples with global headwinds, a segment of smaller UK-listed companies presents distinct opportunities. We examine three firms, each with a market capitalisation over £90 million, that combine financial resilience with specific growth catalysts.
Italian Prime Minister Giorgia Meloni and German Chancellor Friedrich Merz have signed a landmark partnership pact in Rome, signaling a potential shift in the European Union's traditional Franco-German power center. The accord, focusing on defense, migration, and trade, comes as France grapples with political instability and a weakened presidency.
Igor Runets, founder and CEO of Russia's largest Bitcoin mining operator BitRiver, has been detained and placed under house arrest on charges of large-scale tax evasion. The case unfolds against a backdrop of Western sanctions and operational challenges for the once-dominant firm.
As the FTSE 100 hits record highs, a broader rally in UK mid and small-cap indices is prompting a strategic rethink. Analysts debate whether these long-neglected shares, now showing historic undervaluation, are poised for a major comeback.
At 77, Jane Perry's £2 million ISA portfolio stands as a testament to a simple, disciplined investment strategy begun in the 1980s. Her story challenges the gender investment gap and offers a blueprint for long-term wealth building.
As gold and silver surged to record highs last month, Bitcoin's puzzling stagnation below $90,000 had traders searching for answers. A closer look at exchange order books reveals a deliberate play by large players to suppress price—a tactic that ultimately set the stage for last week's sharp decline.
Citing weak network usage and a need to strengthen its economic model, the IP-centric blockchain Story Protocol has pushed back its major token supply unlock by six months to August 2026, aiming to mitigate sell-off risks and buy time for growth.
Bitcoin experienced a sharp, V-shaped recovery after briefly tumbling near $74,000, a swing exacerbated by critically thin market liquidity. The move liquidated over half a billion dollars in leveraged positions, underscoring heightened volatility as traders navigate a market lacking depth.
Amid broader market uncertainty, companies with high insider ownership and robust earnings forecasts can signal aligned interests and resilience. We examine three such UK-listed firms, from a gold miner to a convenience food giant, where those running the show have significant personal stakes.
While Stabilus SE's recent profit figures appeared subdued, a closer examination reveals underlying strength and potential for a rebound, as the market's positive reaction suggests.
The Swiss interdealer broker has delivered a stellar 213% total shareholder return since 2021, fueled by market confidence and robust dividends, despite recent slight pullback.
Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.
